2021-01-06,Windtree Announces First Patient Dosed in its Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19
2020-11-24,WINT: Clinical Studies Moving Forward For Both Lead Treatment Programs
2020-11-16,Windtree Therapeutics Reports Third Quarter 2020 Financial Results and Provides Key Business Updates
2020-10-01,Windtree Announces First Patient Dosed in Phase 2 Study of Istaroxime for the Acute Treatment of Early Cardiogenic Shock in Heart Failure Patients
2020-09-29,Windtree Announces FDA Acceptance of IND Application for a Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19
2020-09-08,Windtree to Present at H.C. Wainwright 22nd Annual Global Investment Conference
2020-08-31,WINT: Advancing Two Lead Fast Track-Designated Drug Candidates Toward Approval & Commercialization
2020-08-13,Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
2020-07-21,Windtree Adds to Team with Appointment of Three Industry Veterans
2020-07-20,Windtree Appoints John Hamill as Chief Financial Officer
2020-06-30,"Did Windtree Therapeutics, Inc. (NASDAQ:WINT) Insiders Buy Up More Shares?"
2020-06-24,Windtree Announces Initial European Trial Sites Activated in AEROSURF® Bridging Study and a Collaboration for a Concomitant Independent Cerebral Physiology Study
2020-05-28,"Windtree to Host Company and Business Update Conference Call on June 4, 2020"
2020-05-22,Windtree Therapeutics Announces Closing of $23 Million Public Offering Including Full Exercise of Over-Allotment Option
2020-05-20,Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
2020-05-14,Windtree Therapeutics Reports First Quarter 2020 Financial Results and Provides Key Business Updates
2020-04-29,Windtree Announces First Patient Enrolled in AEROSURF® Bridging Study for the Treatment of Respiratory Distress Syndrome
2020-04-28,Windtree Therapeutics Announces Reverse Stock Split
2020-04-06,Windtree Presents New Istaroxime Phase 2b Study Analysis at the American College of Cardiology (ACC) Congress
2020-04-02,Windtree Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Key Business Updates
2020-03-31,Windtree Enters into Agreement with Lee's Pharmaceutical for Non-Dilutive Funding of the Continued Development of AEROSURF®
2020-03-24,Windtree to Pursue Clinical Study of Lung Injury Treatment in COVID-19 Patients with its KL4 Surfactant Therapy
2019-12-09,"Windtree to Host a Conference Call on December 11, 2019 to Provide Development Programs and Financial Update"
